Ligand validation:4IB6

DAO: LAURIC ACID

DAO is a Ligand Of Interest in 4IB6 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4IB6_DAO_A_201	24%	60%	0.177	0.804	0.59	0.95	-	-	1	0	100%	0.8
7BH0_DAO_AAA_201	38%	67%	0.167	0.868	0.58	0.68	-	-	0	0	100%	1
7BGA_DAO_AAA_301	34%	69%	0.138	0.82	0.56	0.62	-	-	0	0	100%	1
3UEU_DAO_A_2871	16%	62%	0.192	0.757	0.66	0.8	-	-	2	0	100%	0.75
7ZLF_DAO_AAA_201	14%	66%	0.169	0.718	0.55	0.74	-	-	0	0	100%	1
4TKB_DAO_A_200	99%	68%	0.055	0.986	0.57	0.65	-	-	2	0	100%	0.9286
2WYD_DAO_B_1552	93%	68%	0.065	0.961	0.61	0.62	-	-	0	0	100%	1
6CHT_DAO_B_500	91%	48%	0.099	0.984	0.7	1.28	-	1	2	0	100%	1
1AYM_DAO_1_7009	90%	48%	0.099	0.981	1.28	0.76	1	-	7	0	100%	0.5
3DPR_DAO_A_290	84%	47%	0.108	0.97	0.81	1.21	1	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.